Page 72 - 2022-26-中国全科医学

http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn ·3269·

［19］ARDIZZONI A，CAFFERATA M A，TISEO M，et al. Decline in practice guidelines in oncology［J］. J Natl Compr Canc Netw，
serum carcinoembryonic antigen and cytokeratin 19 fragment during 2019，17（7）：855-883. DOI：10.6004/jnccn.2019.0033.
chemotherapy predicts objective response and survival in patients ［32］DE JONG C，DENEER V H M，KELDER J C，et al. Association
with advanced nonsmall cell lung cancer［J］. Cancer，2006，107 between serum biomarkers CEA and LDH and response in advanced
（12）：2842-2849. DOI：10.1002/cncr.22330. non-small cell lung cancer patients treated with platinum-based
［20］GHOSHAL A，GARMO H，ARTHUR R，et al. Thyroid cancer chemotherapy［J］. Thorac Cancer，2020，11（7）：1790-
risk in the Swedish AMORIS study：the role of inflammatory 1800. DOI：10.1111/1759-7714.13449.
biomarkers in serum［J］. Oncotarget，2017，9（1）：774-782. ［33］SHIBUTANI M，MAEDA K，KASHIWAGI S，et al. Lactate
DOI：10.18632/oncotarget.22891. dehydrogenase is a useful marker for predicting the efficacy of
［21］麦海强，莫浩元，洪明晃，等 . 鼻咽癌放疗前血红蛋白浓度对 bevacizumab-containing chemotherapy in patients with metastatic
局部控制的影响［J］. 癌症，2005，24（6）：727-730. DOI： colorectal cancer［J］. Anticancer Res，2021，41（7）：3535-
10.3321/j.issn:1000-467X.2005.06.020. 3542. DOI：10.21873/anticanres.15141.
MAI H Q，MO H Y，HONG M H，et al. Impact of pre- ［34］BALCH C M，GERSHENWALD J E，SOONG S J，et al. Final
radiotherapy hemoglobin level on local control of nasopharyngeal version of 2009 AJCC melanoma staging and classification［J］.
carcinoma［J］. Chinese Journal of Cancer，2005，24（6）： J Clin Oncol，2009，27（36）：6199-6206. DOI：
727-730. DOI：10.3321/j.issn:1000-467X.2005.06.020. 10.1200/JCO.2009.23.4799.
［22］JIANG R，CAI X Y，YANG Z H，et al. Elevated peripheral blood ［35］SIMEONE E，GENTILCORE G，GIANNARELLI D，et al.
lymphocyte-to-monocyte ratio predicts a favorable prognosis in the Immunological and biological changes during ipilimumab treatment
patients with metastatic nasopharyngeal carcinoma［J］. Chin J and their potential correlation with clinical response and survival
Cancer，2015，34（6）：237-246. DOI：10.1186/s40880-015- in patients with advanced melanoma［J］. Cancer Immunol
0025-7. Immunother，2014，63（7）：675-683. DOI：10.1007/s00262-
［23］WU D Z，ZHONG J M，JIANG W P，et al. Preoperative 014-1545-8.
combination score of neutrophils，monocytes，and lymphocytes as ［36］CHIOU V L，BUROTTO M. Pseudoprogression and immune-related
a predictor for locally advanced rectal cancer［J］. Int J Colorectal response in solid tumors［J］. J Clin Oncol，2015，33（31）：
Dis，2022，37（5）：1097-1106. DOI：10.1007/s00384-022- 3541-3543. DOI：10.1200/JCO.2015.61.6870.
04143-5. ［37］DAI D R，BALEGA J，SUNDAR S，et al. Serum albumin
［24］GATENBY R A，GILLIES R J. Why do cancers have high aerobic as a predictor of survival after interval debulking surgery
glycolysis? ［J］. Nat Rev Cancer，2004，4（11）：891-899. for advanced ovarian cancer （AOC）：a retrospective
DOI：10.1038/nrc1478. study［J］. J Invest Surg，2022，35（2）：426-431. DOI：
［25］YAMADA Y，NAKAMURA K，AOKI S，et al. Lactate 10.1080/08941939.2020.1827314.
dehydrogenase，Gleason score and HER-2 overexpression are ［38］JUNG K，HEISHI T，KHAN O F，et al. Ly6Clo monocytes drive
significant prognostic factors for M1b prostate cancer［J］. Oncol immunosuppression and confer resistance to anti-VEGFR2 cancer
Rep，2011，25（4）：937-944. DOI：10.3892/or.2011.1154. therapy［J］. J Clin Invest，2017，127（8）：3039-3051.
［26］KOUKOURAKIS M I，GIATROMANOLAKI A，SIVRIDIS E， DOI：10.1172/JCI93182.
et al. Lactate dehydrogenase-5 （LDH-5） overexpression in ［39］SIDIBE A，ROPRAZ P，JEMELIN S，et al. Angiogenic factor-
non-small-cell lung cancer tissues is linked to tumour hypoxia， driven inflammation promotes extravasation of human proangiogenic
angiogenic factor production and poor prognosis［J］. Br J Cancer， monocytes to tumours［J］. Nat Commun，2018，9（1）：355.
2003，89（5）：877-885. DOI：10.1038/sj.bjc.6601205. DOI：10.1038/s41467-017-02610-0.
［27］SHARPE A H，FREEMAN G J. The B7-CD28 superfamily［J］. ［40］JEONG J，KIM D K，PARK J H，et al. Tumor-infiltrating
Nat Rev Immunol，2002，2（2）：116-126. DOI： neutrophils and non-classical monocytes may be potential
10.1038/nri727. therapeutic targets for HER2negative gastric cancer［J］. Immune
［28］FRANCISCO L M，SAGE P T，SHARPE A H. The PD-1 pathway Netw，2021，21（4）：e31. DOI：10.4110/in.2021.21.e31.
in tolerance and autoimmunity［J］. Immunol Rev，2010，236： ［41］YOVINO S，KWOK Y，KRASNA M，et al. An association
219-242. DOI：10.1111/j.1600-065X.2010.00923.x. between preoperative Anemia and decreased survival in early-stage
［29］AKIN TELLI T，BREGNI G，CAMERA S，et al. PD-1 and PD- non-small-cell lung cancer patients treated with surgery alone［J］.
L1 inhibitors in oesophago-gastric cancers［J］. Cancer Lett， Int J Radiat Oncol Biol Phys，2005，62（5）：1438-1443.
2020，469：142-150. DOI：10.1016/j.canlet.2019.10.036. DOI：10.1016/j.ijrobp.2004.12.038.
［30］PARDOLL D M. The blockade of immune checkpoints in cancer ［42］EVANS S M，KOCH C J. Prognostic significance of tumor
immunotherapy［J］. Nat Rev Cancer，2012，12（4）：252- oxygenation in humans［J］. Cancer Lett，2003，195（1）：1-16.
264. DOI：10.1038/nrc3239. DOI：10.1016/s0304-3835(03)00012-0.
［31］AJANI J A，D'AMICO T A，BENTREM D J，et al. Esophageal and （收稿日期：2022-02-14；修回日期：2022-06-19）
esophagogastric junction cancers，version 2.2019，NCCN clinical （本文编辑：毛亚敏）